RedHill Biopharma Ltd. (RDHL)

USD 2.07

(-3.72%)

Gross Profit Summary of RedHill Biopharma Ltd.

  • RedHill Biopharma Ltd.'s latest annual gross profit in 2023 was 3.05 Million USD , down -89.24% from previous year.
  • RedHill Biopharma Ltd.'s latest quarterly gross profit in 2023 FY was 3.06 Million USD , down -89.24% from previous quarter.
  • RedHill Biopharma Ltd. reported a annual gross profit of 28.46 Million USD in annual gross profit 2022, down -21.7% from previous year.
  • RedHill Biopharma Ltd. reported a annual gross profit of 36.35 Million USD in annual gross profit 2021, up 32.34% from previous year.
  • RedHill Biopharma Ltd. reported a quarterly gross profit of 1.98 Million USD for 2023 Q1, down -52.69% from previous quarter.
  • RedHill Biopharma Ltd. reported a quarterly gross profit of 3.06 Million USD for 2023 FY, down -89.24% from previous quarter.

Annual Gross Profit Chart of RedHill Biopharma Ltd. (2023 - 2010)

Historical Annual Gross Profit of RedHill Biopharma Ltd. (2023 - 2010)

Year Gross Profit Gross Profit Growth
2023 3.05 Million USD -89.24%
2022 28.46 Million USD -21.7%
2021 36.35 Million USD 32.34%
2020 27.46 Million USD 581.23%
2019 4.03 Million USD -27.0%
2018 5.52 Million USD 193.62%
2017 1.88 Million USD 106.18%
2016 -30.44 Million USD -38.38%
2015 -21.99 Million USD -468.86%
2014 5.96 Million USD 49600.0%
2013 12 Thousand USD -25.0%
2012 16 Thousand USD -30.43%
2011 23 Thousand USD 0.0%
2010 - USD 0.0%

Peer Gross Profit Comparison of RedHill Biopharma Ltd.

Name Gross Profit Gross Profit Difference
Esperion Therapeutics, Inc. 73.06 Million USD 95.82%
Theratechnologies Inc. 62.12 Million USD 95.084%
Safety Shot Inc -74.45 Thousand USD 4201.929%
Cosmos Health Inc. 4.34 Million USD 29.782%
Cronos Group Inc. 6.99 Million USD 56.312%
Ironwood Pharmaceuticals, Inc. 441.16 Million USD 99.308%
Kala Pharmaceuticals, Inc. -303 Thousand USD 1107.978%
Organogenesis Holdings Inc. 309.79 Million USD 99.014%
Universe Pharmaceuticals INC 10.07 Million USD 69.694%
ProPhase Labs, Inc. 16.23 Million USD 81.192%
Sonoma Pharmaceuticals, Inc. 4.74 Million USD 35.634%
Dynavax Technologies Corporation 182.11 Million USD 98.323%
Radius Health, Inc. 307.71 Million USD 99.007%
China SXT Pharmaceuticals, Inc. 553.97 Thousand USD -451.324%
Alvotech -69.42 Million USD 104.399%
Sunshine Biopharma, Inc. 8.33 Million USD 63.376%
Alpha Teknova, Inc. 10.29 Million USD 70.336%
Intra-Cellular Therapies, Inc. 430.62 Million USD 99.291%
SCYNEXIS, Inc. 124.51 Million USD 97.547%
Harrow Health, Inc. 90.55 Million USD 96.627%
Biofrontera Inc. 16.62 Million USD 81.631%
DURECT Corporation 6.83 Million USD 55.29%
Supernus Pharmaceuticals, Inc. 523.74 Million USD 99.417%
ANI Pharmaceuticals, Inc. 305.3 Million USD 99.0%
OptiNose, Inc. 62.35 Million USD 95.102%
Aquestive Therapeutics, Inc. 29.75 Million USD 89.735%
Cumberland Pharmaceuticals Inc. 33.48 Million USD 90.879%
SIGA Technologies, Inc. 122.09 Million USD 97.498%
Lifecore Biomedical, Inc. 41.85 Million USD 92.702%
Shineco, Inc. 882.16 Thousand USD -246.212%
Phibro Animal Health Corporation 312.48 Million USD 99.023%
Procaps Group S.A. 239.56 Million USD 98.725%
TherapeuticsMD, Inc. 1.3 Million USD -134.575%
Regencell Bioscience Holdings Limited -745.58 Thousand USD 509.633%
Viatris Inc. 6.43 Billion USD 99.953%
Sunshine Biopharma, Inc. 8.33 Million USD 63.376%
Rockwell Medical, Inc. 8.7 Million USD 64.911%
Incannex Healthcare Limited 12 Thousand USD -25351.442%
Aytu BioPharma, Inc. 54.58 Million USD 94.405%
Tilray Brands, Inc. 223.35 Million USD 98.633%
Collegium Pharmaceutical, Inc. 326.16 Million USD 99.064%
PetIQ, Inc. 252.74 Million USD 98.792%
Silver Spike Investment Corp. 8.1 Million USD 62.306%
Neurocrine Biosciences, Inc. 1.84 Billion USD 99.835%
Journey Medical Corporation 52.52 Million USD 94.185%
Alimera Sciences, Inc. 61.17 Million USD 95.007%
Petros Pharmaceuticals, Inc. 4.19 Million USD 27.128%
Assertio Holdings, Inc. 125.04 Million USD 97.558%
Shuttle Pharmaceuticals Holdings, Inc. -6811.00 USD 44941.771%
Embecta Corp. 749.9 Million USD 99.593%
Cyclo Therapeutics, Inc. -2.41 Million USD 226.72%
Procaps Group, S.A. 239.56 Million USD 98.725%
PainReform Ltd. -15 Thousand USD 20461.153%
Avadel Pharmaceuticals plc 27.11 Million USD 88.737%
Hempacco Co., Inc. -1.21 Million USD 351.2%
Talphera, Inc. -4.89 Million USD 162.394%
Pacira BioSciences, Inc. 490.3 Million USD 99.377%
Alvotech -69.42 Million USD 104.399%
Lantheus Holdings, Inc. 709.54 Million USD 99.57%
Kamada Ltd. 52.59 Million USD 94.193%
Indivior PLC 907 Million USD 99.663%
Currenc Group, Inc. 17.35 Million USD 82.403%
Evoke Pharma, Inc. 4.97 Million USD 38.656%
Flora Growth Corp. 17.73 Million USD 82.782%
Cyclo Therapeutics, Inc. -2.41 Million USD 226.72%
Evolus, Inc. 140.52 Million USD 97.827%
HUTCHMED (China) Limited 453.55 Million USD 99.327%
Amphastar Pharmaceuticals, Inc. 343.96 Million USD 99.112%
Akanda Corp. 111.44 Thousand USD -2640.422%